Upcoming Events

46th EDTNA/ERCA International Conference

Krakow, Poland
September 9 -12, 2017

Symposium: The DOPPS Program Continues to Grow
Sunday, September 10, 2017: 12:45 PM - 1:45 PM
Theater Hall

Topics/speakers:

  • Key hemodialysis practice changes and their impact – Andrzej Wiecek
  • PDOPPS: Identifying optimal practices in PD – Jen King
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis – Elodie Speyer
  • “Ask your patients and do something about it”: The patient perspective in DOPPS – Jeanette Wallin

 

American Society of Nephrology Kidney Week

New Orleans, LA

Oct. 31 - Nov. 5, 2017


 

Past Events

Japanese Society for Dialysis Therapy (JSDT)

June 16-18, 2017

Yokohama, Japan

DOPPS/ PDOPPS Symposium

June 18, 2017

DOPPS Presentation begins at 8:20 a.m.

PDOPPS presentation begins at 10:20 a.m.


European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 3-6, 2017

Madrid, Spain

 

Symposium: Optimizing care in advanced CKD and the transition to dialysis: Insights from DOPPS Program

June 5, 2017 at 3:15 p.m. 

Session number S 37, Hall 10

Topics and Speakers:

  • The DOPPS Program: invitation to collaborators: Hugh Rayner
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis: Helmut Reichel
  • DOPPS: Impact of clinical practices on early mortality among HD patients: Takeshi Hasegawa
  • PDOPPS: Predictors of early successful PD use: Martin Wilkie
  • Recent results from the EURODOPPS: Ayesha Sajjad

 

Free Communications

Sunday, June 4

  • Cinacalcet discontinuation and its predictors in hemodialysis patients: Results from 7 European countries (#SO034). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Regional variation in mineral and bone disorder (MBD) markers and treatment at dialysis start: Results from the DOPPS (#SO032). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Dialysate calcium concentration <3.0mEq/L is not associated with improved outcomes in the Japan DOPPS (#SO061). Session: Epidemiology in dialysis – 2 (5:00-6:30 p.m.)

Monday, June 5

  • International differences in time from arteriovenous fistula (AVF) creation until becoming catheter-free among HD patients using a catheter at time of AVF creation: Results from the DOPPS (#MO047). Session: Vascular Access (3:15 p.m.)
  • Early Peritoneal Dialysis Attrition: Preliminary Results from The Peritoneal DOPPS (#MO061). Session: Peritoneal dialysis (5:00 p.m.)

 

Posters

Sunday, June 4, 9:30-10:45 a.m.

  • Associations of coping strategies with quality of life, depression and mortality among hemodialysis patients in the DOPPS (#SP623)
  • Hypokalemia in the Peritoneal Dialysis and Outcome Practice Patterns Study (PDOPPS): International variability and clinical predictors (#SP498)
  • International variation in PD catheter practices: Preliminary results from the Peritoneal DOPPS (#SP503)
  • Renin-angiotensin-aldosterone system inhibitors (RAASi) and clinical outcomes in hemodialysis patients: Results from the DOPPS (#SP551)
  • Treatments of mineral and bone disorder may be under-utilized in CKD patients (#SP369)

 

Monday, June 5, 9:30-10:45 a.m.

  • Prevalence of hyperkalemia in DOPPS: A real-world, international cohort of hemodialysis patients (#MP371)
  • Renin-angiotensin-aldosterone system inhibitor prescription patterns in hemodialysis patients: Results from the International DOPPS (#MP385)
  • Variation in Renin Angiotensin Aldosterone System Inhibitor (RAASi) prescription internationally and across CKD stages (#MP409)
  • Regional Differences in the Associations between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the DOPPS: A Call for Quality Assurance? (#MP704)

     


American Society of Nephrology Kidney Week 2016

November 15-20, 2016
Chicago, IL

Featured Posters

          
International variation in dialysis discontinuation: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Abstract #TH-PO1108)    Association between diuretic use and residual kidney function in peritoneal dialysis patients: International comparison from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #SA-PO1102)
 
 
 Also Presented
  • Prevalence and dosing patterns of ESAs used in 9 European countries: DOPPS (Abstract #SA-PO1007)
  • Hyperkalemia and prescription of antihypertensive medications: Early findings from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #SA-PO796)
  • International variations in the frequency of the types of patient-physician contact for CKD patients: Early findings from CKDopps (Abstract #SA-PO927)
  • Geographical and seasonal patterns of blood pressure in hemodialysis patients: A EURODOPPS study (Abstract #TH-PO990)
  •  Higher phosphorus is associated with lower hemoglobin in CKD stages 3-5: Early results from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #FR-PO789)
  •  Facility use of low dialysate temperature for prevention of intra-dialytic hypotension is associated with lower cardiovascular mortality in the DOPPS (Abstract #FR-PO938)